Pediatric Cardio-Oncology Webinars
Welcome to the Pediatric Cardio-Oncology Webinar series, sponsored by Sofia's Hope and hosted by Heart University at Cincinnati Children's. These webinars were held leading up to the 1st and 2nd International Pediatric Cardio-Oncology Conferences held in 2022 and 2024.
August 14, 204
Advanced cardiac therapies in pediatric cardiotoxicity
​
Moderator:
Thomas D. Ryan, MD, PhD
Cincinnati Children’s Hospital
Heart Institute
​
Kriti Puri, MBBS
Baylor College of Medicine
Mechanical Circulatory Support in Pediatric Cardiotoxicity
Matthew J. Bock, MD
Rady Children's Hospital/UC San Diego
Heart Transplantation for Chemotherapy-induced Cardiomyopathy in children
August 24, 2022
A Dex of Cards: Shuffling Through 2022
​
Moderator: Steven Lipshultz, MD
University at Buffalo Jacobs School of
Medicine and Biomedical Sciences; John R. Oishei Children‘s Hospital
​
Joseph R Carver, MD
Seattle Children’s Hospital
Anthracyclines and Dexrazoxane: mechanisms and issue
Elvira van Dalen, MD, PhD
Princess Maxima Center
Dexrazoxane Guidelines
Eric J Chow, MD, MPH
Seattle Children’s
Long-term safety and efficacy of dexrazoxane in pediatric cancer patients
April 12, 2022
A Pediatric Oncologist and Pediatric Cardiologist Walk Into a Bar… Discussions of Interesting and Perplexing Patients Between Colleagues
Kasey Ledger, MD, MSc
Seattle Children’s Hospital
Cancer and Blood Disorders
Thomas D. Ryan, MD, PhD
Cincinnati Children’s Hospital
Heart Institute
Juli Sublet, MSN, APRN-FNP
Cincinnati Children’s Hospital
December 14, 2021
The Role of Risk Prediction Models in Guiding Cardio-Oncology Care
Moderator - Melissa Hudson, MD from St. Jude's Children's Research Hospital
Eric Chow, MD, MPH at Seattle Children's Hospital: Individual Prediction of Heart Failure Among Childhood Cancer Survivors
Jennifer Yeh, PhD at Boston Children's Hospital: Cost-effectiveness of Routine Echocardiography Screening for Asymptomatic Left Ventricular Dysfunction
Jan Leerink - PhD Candidate at Princess Maxima Centrum: Refining the 10-Year Prediction of Left Ventricular Systolic Dysfunction
August 26, 2021
The Pharmacogenetics of Anthracycline-Related Cardiomyopathy in Survivors of Pediatric Cancers
​
Moderator - Greg Armstrong, MD, MSCE from St. Jude Children’s Research Hospital.
Myocardial Determinants for the Metabolism and Toxicity of Anthracycline Drugs by Javier Blanco, PhD, Professor of Pharmacology at University of Buffalo
​
The Pharmacogenetics of Anthracycline-Related Cardiomyopathy in Survivors of Pediatric Cancers by Smita Bhatia, MD and Director of Institute for Cancer Outcomes and Survivorship at UAB
The Role of the Genome in Doxorubicin-Induced Cardiotoxicity by Paul Burridge, PhD, and Assistant Professor of Pharmacology at Northwestern
April 13, 2021
Surveillance for Cardiometabolic Disorders in Children and Adult Survivors of Childhood Cancers
​
Case presentation and Introduction of cardiac risk factors (20 mins)
Ming Hui Chen, MD, MMSc, FACC, FASE
Starting at the beginning - Components of metabolic syndrome and Cardiovascular risk factors in children who survived cancer (20 mins)
Julia Steinberger, MD, MS
Cardiovascular Risk factors and Cardiovascular disease screening in adults who survived childhood cancers - the IGHG CAD guideline (20 mins)
Dan Mulrooney, MD, MS
Impact of alteration in anti-cancer protocols over time, on decreasing CV risk and disease (20 mins)
Elizabeth (Lieke) A. M. Feijen, PhD
Webinar - December 16, 2020
Updates in Pediatric Cardiology
Presenters:
​
Steven Lipshultz, MD | Beginning with the End in Mind: Cardiotoxicity After Childhood Cancer
Thomas Ryan, MD, PhD | Cardio-Pulmonary Exercise Testing and Rehab in Cardio-Oncology
Steven Colan, MD, FACC, FASE | Differential Impact of Myocardial Mechanics in Acute Versus Late Doxorubicin Toxicity